Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

The cream with xyloglucan, pea protein, and cactus extract works as well as the standard treatment for psoriasis and is well-tolerated.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Topical IKKα inhibitors may help prevent CCS tumours.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Membership in a self-help organization is linked to being better informed and having a higher education, but it doesn't clearly affect disease outcomes.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.